CLAIRE M GULMI

CIK 1200152 · CFO · last filed 2026-05-26

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.28M

Companies

5

Total Filings

63

Lifetime Open-Market Net

-$17.16M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CHCT Director 71,523 $17.91 $1.28M $172.1K 18 2026-05-26
Envision Healthcare Corp (EVHCp) Delisted CFO 119,772 $0 5 2017-03-06
AMSURG CORP (AMSGP) Delisted Executive VP & CFO 0 $0 1 2016-12-01
AMSURG CORP (AMSG.P) Delisted Executive VP & CFO 116,848 -$2.81M 7 2016-02-26
AMSURG CORP (AMSG) Delisted Executive VP & CFO 113,896 -$14.53M 29 2014-02-04

Recent Filings · Page 2 of 7

63 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2022-05-09 CHCT Grant (A) +2,693 $0 EDGAR
2021-05-21 CHCT Grant (A) +2,278 $108.0K EDGAR
2021-05-07 CHCT Grant (A) +2,037 $0 EDGAR
2020-05-21 CHCT Grant (A) +2,231 $80.0K EDGAR
2020-05-08 CHCT Mixed +4,575 $97.0K EDGAR
2019-05-31 CHCT Grant (A) +2,104 $80.0K EDGAR
2019-05-17 CHCT Grant (A) +2,017 $0 EDGAR
2018-05-21 CHCT Grant (A) +2,916 $0 EDGAR
2017-04-21 Disp (D) −2,075 -$89.2K
2017-03-06 Envision Healthcare Corp (EVHCp) Delisted Grant (A) +6,666 $0 EDGAR
Showing 1120 of 63
Page 2 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.